🚀 VC round data is live in beta, check it out!

Largest Diagnostics & Genomics Public Companies in Poland

Benchmark revenue and EBITDA valuation multiples for public comps like
Urteste and Read-Gene.

Select Vertical

Select Theme

Select Country


Urteste		Diagnostics & Genomics	$15	-36%	$23M	$23M	—	—
Read-Gene		Diagnostics & Genomics	$2	+34%	$19M	$19M	—	—

Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.